DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 201 filers reported holding DIPLOMAT PHARMACY INC in Q4 2017. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $232,000 | -59.7% | 58,063 | -50.5% | 0.00% | – |
| Q3 2019 | $575,000 | +110.6% | 117,356 | +162.0% | 0.00% | – |
| Q2 2019 | $273,000 | -94.9% | 44,800 | -95.1% | 0.00% | -100.0% |
| Q1 2019 | $5,335,000 | +120.3% | 918,190 | +410.3% | 0.00% | +100.0% |
| Q4 2018 | $2,422,000 | +202.4% | 179,924 | +335.7% | 0.00% | – |
| Q3 2018 | $801,000 | -78.7% | 41,296 | -71.9% | 0.00% | -100.0% |
| Q2 2018 | $3,753,000 | +78.7% | 146,840 | +40.9% | 0.00% | +100.0% |
| Q1 2018 | $2,100,000 | +181.9% | 104,187 | +180.6% | 0.00% | – |
| Q4 2017 | $745,000 | +15.3% | 37,133 | +19.0% | 0.00% | – |
| Q3 2017 | $646,000 | -95.8% | 31,213 | -97.0% | 0.00% | -100.0% |
| Q2 2017 | $15,222,000 | -45.2% | 1,028,500 | -41.0% | 0.01% | -48.0% |
| Q1 2017 | $27,798,000 | +296.5% | 1,742,829 | +213.3% | 0.02% | +257.1% |
| Q4 2016 | $7,010,000 | +130.4% | 556,276 | +412.2% | 0.01% | +133.3% |
| Q3 2016 | $3,042,000 | +1850.0% | 108,605 | +1904.9% | 0.00% | – |
| Q3 2015 | $156,000 | -74.6% | 5,417 | -60.6% | 0.00% | -100.0% |
| Q2 2015 | $615,000 | +1608.3% | 13,733 | +1226.9% | 0.00% | – |
| Q1 2015 | $36,000 | – | 1,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|